Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates.
An increasingly appreciated conundrum in the discovery of antibody drug conjugates (ADCs) is that an antibody that was selected primarily for strong binding to its cancer target may not serve as an optimal ADC. In this study, we performed mechanistic cell-based experiments to determine the correlati...
Main Authors: | John C Zwaagstra, Traian Sulea, Jason Baardsnes, Stevo Radinovic, Yuneivy Cepero-Donates, Alma Robert, Maureen D O'Connor-McCourt, Ilia A Tikhomirov, Maria Luz Jaramillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0226593 |
Similar Items
-
Pathogenic role of IL-15 in non-alcoholic fatty liver disease
by: Cepero Donates, Yuneivy
Published: (2014) -
Assisted Design of Antibody and Protein Therapeutics (ADAPT).
by: Victor Vivcharuk, et al.
Published: (2017-01-01) -
Recapitulation of the anti-Idiotype antibodies as vaccine candidate
by: Ahsan Naveed, et al.
Published: (2018-03-01) -
Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
by: Eric Escobar-Cabrera, et al.
Published: (2017-05-01) -
Presence of anti-Leishmania antibodies in candidates for kidney transplantation
by: Adriana de Oliveira França, et al.
Published: (2020-09-01)